NATIONAL JEWISH HEALTH — History
CCN 060107 | 3-year financial timeline | COVID resilience: 24/100
🛡️ Public data only — no PHI permitted on this instance.
$150M
Latest Revenue (FY2022)
-8.2%
Revenue CAGR (3yr)
-100.0%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $178M | $156M | $150M | -3.6% | -8.2% |
| Operating Expenses | $341M | $346M | $370M | +6.8% | +4.1% |
| Operating Margin | -91.1% | -100.0% | -100.0% | +0.0% | +0.0% |
| Net Income | $-163M | $-190M | $-219M | -15.4% | +0.0% |
| Licensed Beds | 13 | 13 | 13 | +0.0% | +0.0% |
| Total Patient Days | 427 | 436 | 491 | +12.6% | +7.2% |
| Medicare Day % | 52% | 40% | 42% | +2.9% | -10.4% |
| Medicaid Day % | 7% | 17% | 13% | -22.3% | +39.9% |
COVID Impact & Recovery
Resilience Score: 24/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -15.7% ($178M → $150M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-8.2%
This Hospital
+7.6%
State Avg
Latest Margin
-100.0%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $136M | -104.4% |
| FY2024 (proj) | $122M | -108.9% |
| FY2025 (proj) | $108M | -113.3% |